We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Power3 Medical Products, a leading proteomics company, announces the completion
of the latest stage of clinical validation on the NuroPro, a neurodegenerative
disease blood test used as a diagnostic tool in the early stage assessment of
ALS and Alzheimer's, Parkinson's, and other diseases.
A portable device similar to today's home pregnancy tests that can quickly detect
the presence of infectious diseases, including HIV/AIDS and measles, as well
as biological agents such as ricin and anthrax, is the object of a new joint
university/industry research project.
Impliant, a developer of novel posterior motion-preservation and cartilage-protection
devices for spine and joint arthroplasty, has secured more than $18 million
in Series C financing from a group of leading financial and strategic investors.
CPC of America reports that
its subsidiary, Med Enclosure, has initiated the manufacturing and sterilization
of its Rev "A" Internal Puncture Closure Device (MedClose) in preparation
for launching a U.S. (IDE) clinical study.
Becton, Dickinson and Co. has received FDA 510(k) clearance for its BBL CHROMagar
product for the detection of methicillin-resistant Staphylococcus aureus (MRSA).
CryoLife and Endologix have entered into a development and marketing agreement
for the percutaneous or endovascular delivery of CryoLife's BioFoam as a self-expanding
sealant for endovascular aortic aneurysm grafts.
The FDA has approved an expansion of Orqis Medical's clinical trial for the
Cancion CRS therapy, a percutaneous cardiac recovery system being evaluated
for its ability to reverse the consequences of abnormal aortic flow, induce
vasodilatation and improve renal blood flow.
BioCare Systems has received 510(k) clearance from the FDA to market its PremlR818
Infrared Therapy device for the relief musculoskeletal pain associated with
arthritis, neck/back pain, joint sprains and muscle strains.
Ten patients with complete motor and sensory spinal cord injury were implanted
with an experimental device designed to regenerate nerve fibers, promoting some
degree of functional recovery.